Schedule 13G ownership disclosure

VISTAGEN THERAPEUTICS INC

Security class unavailable · CUSIP: 92840H202

Event date: 2022-04-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000905718-22-000607
Form type
SC 13G
Filer
Commodore Capital LP
CIK
CIK 1831942
Filed
Apr 14, 2022
Reporting period
Apr 04, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub